+
in $
-0.29%
Palantir Technologies Inc.
in NT$
-0.80%
China General Plastics Corporation
1305.TW PLTR
Price 12.35 82.14
Movement -NT$ 0.10 -$ 0.24
Market Cap. 7.2 B 187.1 B
Volume 657,350 60.0 M
Volume μ 1.0 M 74.3 M
EPS TTM -0.66 0.20
P/E TTM -18.71 410.70
Dividend Yield TTM 3% -%
Shares Outstanding 581 M 2,278 M
Earnings Call March 5, 2025 Feb. 3, 2025

Financial Comparison

Financial Statements
Click to show
PLTR
1305.TW
    • 2024
    • 2023
    • 2022
    • 2021
    • 2019
    • 2018
Profitability
Industry Average
Profit Margin
+307.95% YoY
-48.72
-0.20
0.09
Gross Margin
+2.56% YoY
0.61
0.79
0.81
Operating Margin
+256.96% YoY
-54.13
-0.08
0.05
EBT Margin
+277.67% YoY
-48.86
-0.19
0.11
ETR
-% YoY
-
-
EPS
+284.24% YoY
-0.46
-0.18
0.10
EPS Dil.
+297.15% YoY
-0.47
-0.18
0.09
ROA
+332.76% YoY
-0.01
-0.11
0.05
ROE
+341.23% YoY
0.36
-0.15
0.06
ROIC
+298.32% YoY
0.15
-0.06
0.03
Takeaways
  • Positive 5Y revenue growth of +24.23% and +112.03% for the past 10 Years
  • The profit margin of 0.09 implies a positive signal, comparing the net margin against the industry avg. of -48.72
Market Prospects
P/E
+120.18% YoY
86.29
-35.45
175.73
P/B
+51.31% YoY
10.60
5.16
10.61
P/TB
+51.31% YoY
10.60
5.16
10.61
Earnings Yield
+595.78% YoY
0.00
-0.03
0.01
Other Metrics
EBITDA[in mil.]
+190.45% YoY
-
-138
153
EBITDA Margin
+205.66% YoY
-54.46
-0.07
0.07
WA[in mil.]
+3.90% YoY
-
2,063
2,147
WA Dil.[in mil.]
+3.90% YoY
-
2,063
2,147
Earnings & Forecasts
  • Hide e
    Reported
    Avg. Estimate
    Beat
    Miss
Next Earnings PLTR 1305.TW
Earnings Call Nov. 4, 2024 Nov. 4, 2024
Avg. EPS Forecast 0.09 -0.01
Potential Delta 2 % %
Avg. Revenue Forecast 701 Mil. 3,072 Mil.
Potential Delta - % - %
Dividends
Company Average
China General Plastics Corporation
NT$0.35
Industry Average
Chemicals - Specialty
NT$0.85

Investor Relations

Index
PLTR
Annual Statement Feb. 20, 2024, midnight
Quarterly Statement Nov. 5, 2024, midnight
Earnings Call Nov. 4, 2024, 8:43 p.m.
Next Earnings Call Feb. 3, 2025
Shareholder Meeting n/a
Dividend n/a
FDA Filing n/a
1305.TW
Annual Statement n/a
Quarterly Statement n/a
Earnings Call n/a
Next Earnings Call March 5, 2025
Shareholder Meeting n/a
FDA Filing n/a
Lobby Disclosure n/a

Strategic Comparison

Risks & Opportunities